These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 21058896)
21. Use of hormonal therapy for menopause in nine European countries. Banks E; Barnes I; Baker K; Key TJ; IARC Sci Publ; 2002; 156():301-3. PubMed ID: 12484192 [No Abstract] [Full Text] [Related]
22. Comparison of health costs associated with treatment of hypertension with a calcium channel blocker and angiotensin-converting enzyme inhibitor in the United States and Japan. Sakamaki Y; Sasamura H; Ikeda S; Ikegami N; Saruta T Hypertens Res; 2006 May; 29(5):333-8. PubMed ID: 16832153 [TBL] [Abstract][Full Text] [Related]
23. The burden of illness associated with renal cell carcinoma in the United States. Lang K; Danchenko N; Gondek K; Schwartz B; Thompson D Urol Oncol; 2007; 25(5):368-75. PubMed ID: 17826652 [TBL] [Abstract][Full Text] [Related]
24. Trends of determinants of hormone therapy use in Italian women attending menopause clinics, 1997-2003. Parazzini F; Menopause; 2008; 15(1):164-70. PubMed ID: 17581495 [TBL] [Abstract][Full Text] [Related]
25. Factors predicting current use of hormone replacement therapy among menopausal Jewish women in Israel. The National Women's Health Interview Survey, 1998. Merom D; Ifrah A; Cohen-Manheim I; Chinich A; Green MS Isr Med Assoc J; 2002 Sep; 4(9):671-6. PubMed ID: 12440227 [TBL] [Abstract][Full Text] [Related]
26. Managed care of hormone replacement therapy in the menopause. Wardle PG Curr Opin Obstet Gynecol; 1997 Aug; 9(4):270-7. PubMed ID: 9263720 [TBL] [Abstract][Full Text] [Related]
28. Estimated annual direct expenditures in the United States as a result of inappropriate hypertension treatment according to national treatment guidelines. Balu S Clin Ther; 2009 Jul; 31(7):1581-94. PubMed ID: 19695408 [TBL] [Abstract][Full Text] [Related]
29. Prevalence and burden of overactive bladder in the United States. Stewart WF; Van Rooyen JB; Cundiff GW; Abrams P; Herzog AR; Corey R; Hunt TL; Wein AJ World J Urol; 2003 May; 20(6):327-36. PubMed ID: 12811491 [TBL] [Abstract][Full Text] [Related]
30. The economic burden of depression in 1990. Greenberg PE; Stiglin LE; Finkelstein SN; Berndt ER J Clin Psychiatry; 1993 Nov; 54(11):405-18. PubMed ID: 8270583 [TBL] [Abstract][Full Text] [Related]
31. Hypertension and menopausal syndrome: effects of hormone replacement therapy and antihypertensive drugs. Amoroso A; Garzia P; Ferri GM; Clementia C; Battaglia T; Clemenzia G Riv Eur Sci Med Farmacol; 1996; 18(4):149-52. PubMed ID: 9177613 [TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness and potential impact of rotavirus vaccination in the United States. Widdowson MA; Meltzer MI; Zhang X; Bresee JS; Parashar UD; Glass RI Pediatrics; 2007 Apr; 119(4):684-97. PubMed ID: 17403839 [TBL] [Abstract][Full Text] [Related]
34. The 25-year health care costs of women who remain overweight after 40 years of age. Gorsky RD; Pamuk E; Williamson DF; Shaffer PA; Koplan JP Am J Prev Med; 1996; 12(5):388-94. PubMed ID: 8909650 [TBL] [Abstract][Full Text] [Related]
35. Permanent cessation of menses and postmenopausal hormone use in dialysis-dependent women: the HELP study. Kramer HM; Curhan GC; Singh A; Am J Kidney Dis; 2003 Mar; 41(3):643-50. PubMed ID: 12612988 [TBL] [Abstract][Full Text] [Related]
36. The effect of menopause, hormone replacement therapy (HRT), alendronate (ALN), and calcium supplements on saliva. Yalçin F; Gurgan S; Gurgan T J Contemp Dent Pract; 2005 May; 6(2):10-7. PubMed ID: 15915200 [TBL] [Abstract][Full Text] [Related]
37. The health and economic burden of genital warts in a set of private health plans in the United States. Insinga RP; Dasbach EJ; Myers ER Clin Infect Dis; 2003 Jun; 36(11):1397-403. PubMed ID: 12766834 [TBL] [Abstract][Full Text] [Related]
38. Understanding the menopausal experiences of professional women. Simon JA; Reape KZ Menopause; 2009; 16(1):73-6. PubMed ID: 18779760 [TBL] [Abstract][Full Text] [Related]
39. Costs and utilization of end-stage glaucoma patients receiving visual rehabilitation care: a US multisite retrospective study. Gieser DK; Tracy Williams R; O'Connell W; Pasquale LR; Rosenthal BP; Walt JG; Katz LM; Siegartel LR; Wang L; Rosenblatt LC; Stern LS; Doyle JJ J Glaucoma; 2006 Oct; 15(5):419-25. PubMed ID: 16988605 [TBL] [Abstract][Full Text] [Related]
40. The burden of illness associated with hepatocellular carcinoma in the United States. Lang K; Danchenko N; Gondek K; Shah S; Thompson D J Hepatol; 2009 Jan; 50(1):89-99. PubMed ID: 18977551 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]